J
Jeff D. Williamson
Researcher at Wake Forest University
Publications - 310
Citations - 46245
Jeff D. Williamson is an academic researcher from Wake Forest University. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 73, co-authored 271 publications receiving 38119 citations. Previous affiliations of Jeff D. Williamson include University of Maryland, Baltimore & Florey Institute of Neuroscience and Mental Health.
Papers
More filters
Journal Article
The Intensive Diet and Exercise for Arthritis Trial: 18-Month Clinical Outcomes.
Steven P. Messier,Barbara J. Nicklas,Claudine Legault,Shannon L. Mihalko,Gary D. Miller,Paul DeVita,Mary F. Lyles,David J. Hunter,Felix Eckstein,Jeff D. Williamson,J. Jeffrey Carr,Richard F. Loeser +11 more
Journal ArticleDOI
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
Jordana B. Cohen,Zachary A. Marcum,Chong Zhang,Catherine G. Derington,Tom Greene,Lama Ghazi,Jennifer S. Herrick,Jordan B. King,Alfred K. Cheung,Nick Bryan,Mark A. Supiano,Joshua A. Sonnen,William S. Weintraub,Daniel Scharfstein,Jeff D. Williamson,Nicholas M. Pajewski,Adam P. Bress +16 more
TL;DR: The findings of this study suggest that pragmatic trials reflective of blood pressure management outside the clinical trial setting are warranted to further elucidate cognitive outcomes with ARBs vs ACEIs initiation.
Journal ArticleDOI
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
Manjula Kurella Tamura,Sarah A. Gaussoin,Nicholas M. Pajewski,Greg Zaharchuk,Barry I. Freedman,Stephen R. Rapp,Alexander P. Auchus,William E. Haley,Suzanne Oparil,Jessica Kendrick,Christianne L. Roumie,Srinivasan Beddhu,Alfred K. Cheung,Jeff D. Williamson,John A. Detre,Sudipto Dolui,R. Nick Bryan,Ilya M. Nasrallah +17 more
TL;DR: In this article, the effects of hypertension treatment on cerebral perfusion and structure in those with and without CKD were studied in a randomized clinical trial, and the findings support the safety of intensive blood pressure treatment targets on brain health.